vs
Side-by-side financial comparison of Bolt Biotherapeutics, Inc. (BOLT) and ELECTRO SENSORS INC (ELSE). Click either name above to swap in a different company.
ELECTRO SENSORS INC is the larger business by last-quarter revenue ($2.8M vs $2.5M, roughly 1.1× Bolt Biotherapeutics, Inc.). ELECTRO SENSORS INC runs the higher net margin — 3.7% vs -265.2%, a 269.0% gap on every dollar of revenue. Over the past eight quarters, ELECTRO SENSORS INC's revenue compounded faster (10.8% CAGR vs -31.2%).
Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company specializing in immune-stimulating antibody conjugate (ISAC) therapies for cancer treatment. Its core pipeline targets hard-to-treat solid tumors, serving global oncology markets and advancing novel immunotherapies that trigger targeted anti-tumor immune responses to improve patient outcomes.
Polar Electro Oy is a Finnish manufacturer of sports training computers, particularly known for developing the world's first wireless heart rate monitor.
BOLT vs ELSE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.5M | $2.8M |
| Net Profit | $-6.6M | $103.0K |
| Gross Margin | — | 50.3% |
| Operating Margin | -283.4% | -0.3% |
| Net Margin | -265.2% | 3.7% |
| Revenue YoY | — | 14.8% |
| Net Profit YoY | 58.4% | -48.8% |
| EPS (diluted) | $-9.38 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.5M | $2.8M | ||
| Q3 25 | $2.2M | $2.7M | ||
| Q2 25 | $1.8M | $2.4M | ||
| Q1 25 | $1.2M | $2.2M | ||
| Q4 24 | $0 | $2.4M | ||
| Q3 24 | $1.1M | $2.5M | ||
| Q2 24 | $1.3M | $2.2M | ||
| Q1 24 | $5.3M | $2.2M |
| Q4 25 | $-6.6M | $103.0K | ||
| Q3 25 | $-7.1M | $208.0K | ||
| Q2 25 | $-8.6M | $59.0K | ||
| Q1 25 | $-11.0M | $-64.0K | ||
| Q4 24 | $-15.9M | $201.0K | ||
| Q3 24 | $-15.2M | $238.0K | ||
| Q2 24 | $-21.2M | $-4.0K | ||
| Q1 24 | $-10.8M | $11.0K |
| Q4 25 | — | 50.3% | ||
| Q3 25 | — | 53.1% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | 49.6% | ||
| Q3 24 | — | 50.4% | ||
| Q2 24 | — | 47.2% | ||
| Q1 24 | — | 48.1% |
| Q4 25 | -283.4% | -0.3% | ||
| Q3 25 | -355.1% | 6.6% | ||
| Q2 25 | -510.5% | -0.1% | ||
| Q1 25 | -991.4% | -7.5% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | -1441.1% | 6.9% | ||
| Q2 24 | -1772.3% | -4.8% | ||
| Q1 24 | -324.1% | -4.5% |
| Q4 25 | -265.2% | 3.7% | ||
| Q3 25 | -329.4% | 7.6% | ||
| Q2 25 | -474.6% | 2.5% | ||
| Q1 25 | -903.4% | -2.9% | ||
| Q4 24 | — | 8.4% | ||
| Q3 24 | -1330.1% | 9.5% | ||
| Q2 24 | -1662.4% | -0.2% | ||
| Q1 24 | -205.0% | 0.5% |
| Q4 25 | $-9.38 | $0.03 | ||
| Q3 25 | $-3.72 | $0.06 | ||
| Q2 25 | $-4.46 | $0.02 | ||
| Q1 25 | $-0.29 | $-0.02 | ||
| Q4 24 | $-13.73 | $0.06 | ||
| Q3 24 | $-7.93 | $0.07 | ||
| Q2 24 | $-11.12 | $0.00 | ||
| Q1 24 | $-0.28 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $27.5M | $10.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $26.5M | $14.8M |
| Total Assets | $56.7M | $15.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.5M | $10.6M | ||
| Q3 25 | $31.9M | $10.6M | ||
| Q2 25 | $34.8M | $10.2M | ||
| Q1 25 | $38.8M | $10.0M | ||
| Q4 24 | $47.3M | $10.0M | ||
| Q3 24 | $53.8M | $10.3M | ||
| Q2 24 | $73.7M | $9.9M | ||
| Q1 24 | $91.3M | $10.1M |
| Q4 25 | $26.5M | $14.8M | ||
| Q3 25 | $32.1M | $14.7M | ||
| Q2 25 | $38.8M | $14.4M | ||
| Q1 25 | $46.8M | $14.3M | ||
| Q4 24 | $57.2M | $14.3M | ||
| Q3 24 | $72.0M | $14.1M | ||
| Q2 24 | $85.9M | $13.8M | ||
| Q1 24 | $104.2M | $13.8M |
| Q4 25 | $56.7M | $15.7M | ||
| Q3 25 | $65.1M | $15.7M | ||
| Q2 25 | $75.5M | $15.2M | ||
| Q1 25 | $85.9M | $15.1M | ||
| Q4 24 | $99.6M | $14.9M | ||
| Q3 24 | $109.3M | $15.0M | ||
| Q2 24 | $124.2M | $14.5M | ||
| Q1 24 | $142.9M | $14.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.2M | $20.0K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 0.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-7.2M | $20.0K | ||
| Q3 25 | $-9.7M | $395.0K | ||
| Q2 25 | $-9.6M | $277.0K | ||
| Q1 25 | $-13.4M | $-30.0K | ||
| Q4 24 | $-14.4M | $-277.0K | ||
| Q3 24 | $-14.0M | $362.0K | ||
| Q2 24 | $-16.1M | $-158.0K | ||
| Q1 24 | $-16.8M | $202.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | $389.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-298.0K | ||
| Q3 24 | $-14.0M | $358.0K | ||
| Q2 24 | — | $-184.0K | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 14.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -12.4% | ||
| Q3 24 | -1227.6% | 14.3% | ||
| Q2 24 | — | -8.3% | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | 3.6% | 0.2% | ||
| Q2 24 | 0.0% | 1.2% | ||
| Q1 24 | 0.0% | 0.0% |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | 1.90× | ||
| Q2 25 | — | 4.69× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -1.38× | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 18.36× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
